Nano-X Imaging, an Israel-based radiology vendor, is facing significant financial challenges, reporting a net loss of $14.3 million for its quarterly earnings, an increase of 8% from the previous year. The company has a cash balance of approximately $27 million and is experiencing negative cash flow, raising concerns about its viability as it may need to seek additional funding through private equity and capital markets. Following its earnings report, Nano-X's shares dropped by 35%. The company is also dealing with a class-action lawsuit from investors alleging it made misleading statements regarding its manufacturing and production operations. Additionally, challenges with its South Korean operations have led to considerations of downsizing those activities. CEO Erez Meltzer mentioned that the company is focusing on partnerships and optimizing its cost structure to ensure sustainable growth, while it has suspended its revenue forecasts for 2026 due to ongoing operational hurdles.
Mon, 29 Jun 2026 06:07:24 GMT | Radiology Business